Evaxion A/S (NasdaqCM: EVAX)
Health Care · Biotechnology · DK
$2.83
-7.82% today · -60.1% 1Y
Evaxion A/S (NasdaqCM: EVAX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $23.60M and employs 46 people.
Over the last twelve months the share price has lost 60.1%, trading between 2.72 and 9.50.
Tweenvest scores Evaxion A/S across four factors: quality 36/100, value 79/100. Its strongest factor is value.
EVAX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.60M
- Revenue (TTM)
- $7.49M
- P/E
- —
- EPS
- -1.09
- Dividend yield
- —
- Beta (5Y)
- 0.51
- 52-week high
- $9.50
- 52-week low
- $2.72
- Avg volume (3M)
- —
- Shares outstanding
- 8.34M
- Employees
- 46
- Next earnings
- —
About Evaxion A/S
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
- ISIN
- US29970R3030
- Founded
- 2008
- Listed since
- Feb 5, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ABVC BioPharma, Inc.NasdaqCM: ABVC | $23.80M | $0.92 | -8.21% |
| Xbrane Biopharma AB (publ)OM: XBRANE | $23.72M | Skr11.40 | -18.28% |
| GeneMatrix Inc.KOSDAQ: A109820 | $23.69M | ₩1,549.00 | -9.94% |
| Transgenic Group Inc.TSE: 2342 | $23.63M | ¥224.00 | -4.27% |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.IBSE: RTALB | $23.42M | TL2.32 | -10.77% |
| BeyondSpring Inc.NasdaqCM: BYSI | $22.99M | $0.56 | -7.66% |
| FF EAI Robotics Ecosystem Inc.NasdaqCM: FFR | $22.87M | $1.13 | +13.00% |
| Grace Breeding LtdTASE: GRAC | $22.64M | ₪16.47 | +1.92% |
Figures last refreshed Oct 18, 2026.